Page 43 - Read Online

D'Souza et al. J Cancer Metastasis Treat 2022;8:28 https://dx.doi.org/10.20517/2394-4722.2022.51 Page 15 of 15

94. Choi BD, Yu X, Castano AP, et al. CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity. Nat
Biotechnol 2019;37:1049-58. DOI PubMed
95. Chintala NK, Restle D, Quach H, et al. CAR T-cell therapy for pleural mesothelioma: Rationale, preclinical development, and clinical
trials. Lung Cancer 2021;157:48-59. DOI PubMed PMC
96. Sánchez-Paulete AR, Teijeira A, Cueto FJ, et al. Antigen cross-presentation and T-cell cross-priming in cancer immunology and
immunotherapy. Ann Oncol 2017;28:xii44-55. DOI
97. Gulley JL, Madan RA, Pachynski R, et al. Role of antigen spread and distinctive characteristics of immunotherapy in cancer
treatment. J Natl Cancer Inst 2017:109. DOI PubMed PMC
98. Kim RH, Plesa G, Gladney W, et al. Effect of chimeric antigen receptor (CAR) T cells on clonal expansion of endogenous non-CAR
T cells in patients (pts) with advanced solid cancer. JCO 2017;35:3011-3011. DOI
99. Lai J, Mardiana S, House IG, et al. Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives
epitope spreading and antitumor immunity. Nat Immunol 2020;21:914-26. DOI PubMed
100. Xin G, Khatun A, Topchyan P, et al. Pathogen-boosted adoptive cell transfer therapy induces endogenous antitumor immunity
through antigen spreading. Cancer Immunol Res 2020;8:7-18. DOI PubMed PMC